These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 380517)

  • 1. [Oral contraception and multiple sclerosis].
    Ghezzi A; Caputo D; Manara F; Mainini E
    Arch Sci Med (Torino); 1979; 136(1):67-73. PubMed ID: 380517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Estrogen/progestogen-exposure and fetal effects].
    Forsberg JG
    Tidsskr Nor Laegeforen; 1977 Oct; 97(30):1583-4. PubMed ID: 929540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Contraception and arterial hypertension].
    Corvol P; Millet D; Keledjian P
    Acquis Med Recent; 1977; ():177-80. PubMed ID: 910596
    [No Abstract]   [Full Text] [Related]  

  • 7. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of folic acid blood levels during estro-progestagen treatments].
    Karlin R; Dumont M; Long B
    J Gynecol Obstet Biol Reprod (Paris); 1977 Jun; 6(4):489-95. PubMed ID: 915210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possible interference of synthetic estroprogestins with thyroid hormone production].
    Paggi A; Leri O; Evangelista M; Manfredi F; Coarelli C; Loiacono C; Cassone R
    Clin Ter; 1981 Aug; 98(4):349-63. PubMed ID: 7285541
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemostatic system changes induced by 50 micrograms and 30 micrograms estrogen/progestogen oral contraceptives. Modification of estrogen effects by levonorgestrel.
    Sabra A; Bonnar J
    J Reprod Med; 1983 Jan; 28(1 Suppl):85-91. PubMed ID: 6834350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Births following oral contraceptive failures.
    Harlap S; Eldor J
    Obstet Gynecol; 1980 Apr; 55(4):447-52. PubMed ID: 7366901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and blood coagulation.
    Bonnar J; Sabra AM
    J Reprod Med; 1986 Jun; 31(6 Suppl):551-6. PubMed ID: 2941571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
    Batzer FR
    J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.
    Ferreira AC; Montes MB; Franceschini SA; Toloi MR
    Int J Fertil Womens Med; 2001; 46(5):265-70. PubMed ID: 11720199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis of the intracranial venous sinuses after ingestion of estroprogestative agents. 4 cases].
    Rousseaux P; Bernard MH; Scherpereel B; Morel M; Guyot JF
    Nouv Presse Med; 1977 Jun; 6(23):2049, 2051-4. PubMed ID: 887403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and metabolic effects of oral contraceptives].
    Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
    Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral contraceptives and blood platelets].
    Davenas E; Ciavatti M; Poitevin B; Aubin M
    Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension.
    Pritchard JA; Pritchard SA
    Am J Obstet Gynecol; 1977 Dec; 129(7):733-9. PubMed ID: 607805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.